SOPHiA GENETICS SA (SOPH)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about SOPHiA GENETICS SA (SOPH)
Go deeper and ask any question about SOPH
Company Performance
Current Price
as of Sep 13, 2024$4.01
P/E Ratio
N/A
Market Cap
$262.15M
Description
SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.
Metrics
Overview
- HQRolle, VD
- SectorTechnology Services
- IndustryPackaged Software
- TickerSOPH
- Price$4.01+2.82%
Trading Information
- Market Cap$262.15M
- Float70.99%
- Average Daily Volume (1m)61,770
- Average Daily Volume (3m)75,257
- EPS-$1.02
Company
- Revenue$64.94M
- Rev Growth (1yr)5.01%
- Net Income-$15.19M
- Gross Margin68.17%
- EBITDA Margin-82.15%
- EBITDA-$12.99M
- EV$226.57M
- EV/Revenue3.49
- P/EN/A
- P/S4.07